摘要
阻塞性睡眠呼吸暂停低通气综合征(OSAHS)是一种睡眠时伴有鼾声、呼吸暂停、缺氧、白天嗜睡等症状的慢性睡眠呼吸疾病。OSAHS患者心脑血管疾病发病率较高,与促红细胞生成素、血液流变学异常、炎性因子有一定关系。在临床上,持续气道正压通气(CPAP)被作为治疗OSAHS的主要方法之一。检测OSAHS患者治疗前及经CPAP治疗后的血液流变学、促红细胞生成素、炎性因子的变化,这些客观指标为CPAP治疗OSAHS患者提供可靠的疗效依据。
Obstructive sleep apnea-hypopnea syndrome(OSAHS) is a chronic sleep respiratory disease associated with snoring,apnea,hypoxia and daytime sleepiness.The incidence of cardiovascular and cerebrovascular diseases in patients with OSAHS is higher,which is related to erythropoietin,abnormal hemorheology and inflammatory factors.In clinic,continuous positive airway pressure(CPAP) is regarded as one of the main methods to treat OSAHS.To detect the changes of hemorheology,erythropoietin and inflammatory factors in OSAHS patients before and after CPAP treatment.These objective indexes provide reliable therapeutic basis for CPAP treatment of OSAHS patients.
引文
[1]陈光辉,刘玲玲,王士雯,等.睡眠呼吸暂停综合征与心脑血管疾病的相关性研究[J].中国临床康复,2004,8(6):1039-1041.
[2]孙剑芳,徐积兄.2型糖尿病与阻塞性睡眠呼吸暂停低通气综合征的研究进展[J].实用医学杂志,2014,30(3):493.
[3]唐爱英,傅燕虹.阻塞性睡眠呼吸暂停低通气综合征与心血管疾病相关的研究概况[J].右江医学,2014,42(1):103.
[4]段群.血液流变学检测的影响因素[J].临床合理用药杂志,2013,6(8):83.
[5]刘业军,张承宏,刘建设,等.持续气道正压通气对阻塞性睡眠呼吸暂停低通气综合征患者血液流变学及炎性因子变化的研究[J].海南医学院学报,2016,22(4):336-339.